Resolution: standard / high
Figure 2.
Geometric mean titre ratios (Day22:Day1) in all subjects in the Phase II/III trial.
Li et al. Immunity & Ageing 2008 5:2 doi:10.1186/1742-4933-5-2
Download authors' original image
|
Resolution: standard / high Figure 2.
Geometric mean titre ratios (Day22:Day1) in all subjects in the Phase II/III trial.
Li et al. Immunity & Ageing 2008 5:2 doi:10.1186/1742-4933-5-2 |